Macroaxis: Personalized Investing  
Macroaxis Country Selector USA  Change      Macroaxis User Registration Register    Macroaxis User Login Sign In
   
 US Market Open: Feb 9, 11:46 AM 2012 
  NYSE  8066.94  16.04  Index Moved Down   NASDAQ  2915.87  0.01  Index Moved Up 
 and more..
Search
sponsered by
  
  



Processing
Collecting necessary data for PRGO...
94.09
  
Perrigo Quote
Intraday
 
Perrigo Intraday Quote
One Month
 0.14   Macroaxis: 0.15 Up   0.15%  
 70.94 Year To Date 104.7 
 93.0 Trading Day  94.36 
    
Diversification Suggestion
Use Perrigo to enhance returns of your portfolios. The stock experiences normal upward fluctuation
1 Month Beta vs NYSE ......... 1.0
Perrigo returns are very sensitive to returns on the market. As NYSE goes up or down, Perrigo is expected to follow
Perrigo llmost one Beta
    
PRGO Macroaxis: United States NASDAQPerrigo Quote: Bull
Perrigo Company
http://www.perrigo.com
269-673-8451
Trade Perrigo
Run Report
 Run Report 
Correlation
 Correlation 
Drug Related Products  
Market Capitalization 8.768B  
Earnings Per Share 3.577  
Today Lowest 93.00  
Book Value Per Share 16.553  
 Joseph C. Papa  executive  Joseph C. Papa
Chairman, Chief Officer and Pres 
 Judy L. Brown  executive  Judy L. Brown
Chief Financial Officer, Chief Acco 
 John T. Hendrickson  executive  John T. Hendrickson
VP of Global Operations and Supply 
 Todd W. Kingma  executive  Todd W. Kingma
Vice president, Sec. and Gen. Coun 
 Refael  Lebel  executive  Refael Lebel
VP and Pres of Perrigo Israel 

Perrigo fundamentals

    
P/E26.26Open94.21
P/B Ratio5.68Volume287194
SectorHealthcareLast Close93.945
Short Ratio2.20Last Traded2/9/2012
Year High104.70Percent ChangePrice Moved Up 0.15%
Year Low70.94Absolute Change0.14 Price Moved Up
EPS3.577Index MembershipNot Applicable
PEG Ratio1.52Employees8,660
Day High94.36Day Low93.00
Target Price105.21Current EPS3.577
This Year EPS4.77Next Year EPS5.39
Current PE26.26This Year PE19.69
Next Year PE17.43Dividend0.29
Dividend Yield0.31Dividend DateMar 20
    

Perrigo Performance    Embed Financials for Perrigo Company

    
    
 Embed Financials for Perrigo Company

Perrigo Profile

    
Perrigo Company, through its subsidiaries, develops, manufactures, and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, and active pharmaceutical ingredients (API) worldwide.
 Macroaxis: thisGreen PRGO   0.15 % Macroaxis: 0.15 Moved Up  
 
 Macroaxis: United States IXIC   0.00 % No Change  
 Macroaxis: United States GSPC   0.18 % Macroaxis: 0.18 Moved Down  
 
 Macroaxis: United States NYA   0.20 % Macroaxis: 0.2 Moved Down  
 
 Live Sentiment  
 Bulls THRX 
 NGM Macroaxis: United States 
 Bought over 100 shares of
 25 minutes ago
for 17.9 
 Bulls XOMA 
 NGM Macroaxis: United States 
 Bought over 100 shares of
 25 minutes ago
for 1.58 
 Bulls MEMS 
 NGM Macroaxis: United States 
 Bought over 500 shares of
 42 minutes ago
for 3.02 
 Bulls TUNE 
 N/A Macroaxis: United States 
 Bought over 500 shares of
 42 minutes ago
for 2.92 
 Bulls STAA 
 NGM Macroaxis: United States 
 Bought over 100 shares of
 42 minutes ago
for 10.97 
    

Perrigo 30-Days Moving Rating

    

Macroaxis Total Score 

    
8
Current 30 Days Moving Rating
    
    

Estimated Market Risk

 1.21
  actual daily
 
 80 %
of total potential
 
Market Risk score

Expected Return

 -0.24
  actual daily
 
 1 %
of total potential
 
Expected Return score

Risk-Adjusted Return

 -0.2
  actual daily
 
 1 %
of total potential
 
Risk-Adjusted Return score
Based on monthly moving average   [ change ] 
Increase Risk-Adjusted return of PRGO by adding it to a well-diversified portfolio
    

 Perrigo Last Intraday

    
 
0.14Macroaxis: 0.145 Down0.15%
 
93.945,93.945,94.09,94.09,93.00,94.36,94.09
 
93.9594.09
    

Latest headlines for Perrigo


Stocks Lower in Early Trading on Persistent Greek Debt Worries

Stocks are lower in early trading today on persistent worries about Greece. The debt-laden country is yet to strike a deal with its international lenders on next round of bailout funds.

Perrigo beats the analysts' consensus

The pharmaceutical company reported double digit growth in revenue and profit for the second fiscal quarter of 2012. Perrigo Company (Nasdaq:PRGO; TASE:PRGO) posted double-digit growth for its second fiscal quarter of 2012, beating the analysts' ... PERRIGO COMPANY : Perrigo Reports Record Quarterly Revenue and Earnings - 4-traders (press release)

Perrigo Reports Record Quarterly Revenue and Earnings

By Perrigo Company ALLEGAN, Mich., Feb. 7, 2012 -- /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced results for its second quarter and six months ended December 31, 2011.

The Perrigo Company Raises Low End Of Prior FY 2012 EPS Guidance To A Range In Line With Analysts' Estimat...

Reuters Key Development - Feb 7, 2012

Perrigo Earnings Preview

DailyFinance - Feb 3, 2012 By Motley Fool Staff Posted 1:56PM 02/03/12 Investing Investors are on the edge of their seats, hoping that Perrigo (NAS: PRGO) will top analyst expectations for the fifth consecutive quarter.